Literature DB >> 22652519

[Bronchiolitis among infants under 1 year of age in France: epidemiology and factors associated with mortality].

D Che1, J Nicolau, J Bergounioux, T Perez, D Bitar.   

Abstract

Little information is available on the characteristics of infants hospitalized for acute bronchiolitis in France. An analysis of hospital records (PMSI) was conducted at the national level to describe the cases of bronchiolitis that require hospitalization among infants under 1 year of age and the factors associated with death. The analysis of all admissions that occurred during 2009, for which the diagnosis of acute bronchiolitis was recorded in the PMSI database for infants aged less than 1 year, was performed. Cases were described according to age, sex, underlying conditions (including bronchopulmonary dysplasia, cystic fibrosis, and congenital heart disease), length of hospital stay, recurrent admissions, admission to an intensive care unit (ICU), and use of assisted ventilation. Factors associated with death during hospitalization were studied by logistic regression. The hospitalization rate was 35.8 per 1000 infants under 1 year in 2009 in France. Approximately 10% of hospitalized infants required ICU admission. Twenty-two infants died. The estimated case-fatality rate was 0.08% among hospitalized infants and 0.56% for those hospitalized in the ICU. Mortality among all infants under 1 year was 2.6/10(5) in France. Factors associated with death were bronchopulmonary dysplasia (OR=6.7, 95% CI [1.5-29.8]), hospitalization in an ICU (OR=6.46, 95% CI [2.4-17.4]), and the use of assisted ventilation (OR=6.2, 95% CI [2.2-17.1]). This study has enabled the quantification of the rate of hospitalization and mortality, and a better description of infants who need hospitalization. The results are consistent with international literature, but further prospective analysis will be needed to better describe the cases at higher risk, aiming to improve their management.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22652519     DOI: 10.1016/j.arcped.2012.04.015

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  6 in total

1.  Risk of Readmission for Wheezing during Infancy in Children with Congenital Diaphragmatic Hernia.

Authors:  Gregoire Benoist; Mostafa Mokhtari; Antoine Deschildre; Naziha Khen-Dunlop; Laurent Storme; Alexandra Benachi; Christophe Delacourt
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

2.  [Winter viral ecology in a pediatric intensive care unit: a prospective study].

Authors:  G Mortamet; R Morello; M Jokic; A Vabret; M Leroux; J Brouard; J Dina
Journal:  Arch Pediatr       Date:  2014-12-19       Impact factor: 1.180

3.  Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthma.

Authors:  Christopher A Green; David Yeates; Allie Goldacre; Charles Sande; Roger C Parslow; Philip McShane; Andrew J Pollard; Michael J Goldacre
Journal:  Arch Dis Child       Date:  2015-09-04       Impact factor: 3.791

4.  Prematurity, a significant predictor for worse outcome in viral bronchiolitis: a comparative study in infancy.

Authors:  Noussa R El Basha; Huda Marzouk; May M Sherif; Amani A El Kholy
Journal:  J Egypt Public Health Assoc       Date:  2019-03-22

5.  Risk factors for bronchiolitis hospitalization in infants: A French nationwide retrospective cohort study over four consecutive seasons (2009-2013).

Authors:  Brigitte Fauroux; Jean-Michel Hascoët; Pierre-Henri Jarreau; Jean-François Magny; Jean-Christophe Rozé; Elie Saliba; Michaël Schwarzinger
Journal:  PLoS One       Date:  2020-03-06       Impact factor: 3.240

6.  Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018.

Authors:  C Demont; N Petrica; I Bardoulat; S Duret; L Watier; A Chosidow; M Lorrot; A Kieffer; M Lemaitre
Journal:  BMC Infect Dis       Date:  2021-08-02       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.